Published in Pharma Law Weekly, August 17th, 2004
The suit had been initiated by Janssen in April 2001 in response to Eon's filing of a paragraph IV certification under the Hatch-Waxman Act.
The judge upheld the validity of the patent, but found Eon's product did not infringe the patent.
The company will appeal the decision to the Court of Appeals for the Federal Circuit in Washington, D.C.
This article was prepared by Pharma Law Weekly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly